Exposure to electromagnetic fields may cause breast cancer in women if it increases susceptibility to sex-hormone-related cancer by diminishing the pineal gland's production of melatonin. We have studied breast cancer incidence in female radio and telegraph operators with potential exposure to light at night, radio frequency (405 kHz-25 MHz), and, to some extent, extremely low frequency fields (50 Hz). We linked the Norwegian Telecom cohort of female radio and telegraph operators working at sea to the Cancer Registry of Norway to study incident cases of breast cancer. The cohort consisted of 2,619 women who were certified to work as radio and telegraph operators between 1920 and 1980. Cancer incidence was analyzed on the basis of the standardized incidence ratio (SIR), with the Norwegian female population as the comparison group. The incidence of all cancers was close to unity (SIR=1.2). An excess risk was seen for breast cancer (SIR=1.5). Analysis of a nested case-control study within the cohort showed an association between breast cancer in women aged 50 + years and shift work. In a model with adjustment for age, calendar year, and year of first birth, the rate ratio for breast cancer associated with being a radio and telegraph operator-in comparison with all Norwegian women born 1935 or later-analyzed with Poisson regression, was 1.5 after adjustment for fertility factors. These results support a possible association between work as a radio and telegraph operator and breast cancer. Future epidemiologic studies on breast cancer in women aged 50 and over, should address possible disturbances of chronobiological parameters by environmental factors.
Similar content being viewed by others
References
Wertheimer N, Leeper E. Electrical wiring configuration and childhood cancer. Am J Epidemiol 1979; 109: 273–84.
Milham S. Mortality from leukemia in workers exposed to electrical and magnetic fields. N Engl J Med 1982; 307: 249.
Feychting M, Ahlbom A. Magnetic fields and cancer in children residing near Swedish high-voltage power lines. Am J Epidemiol 1993; 138: 467–81.
Loomis DP, Savitz DA, Ananth CV. Breast cancer mortality among female electrical workers in the United States. JNCI 1994; 86: 921–5.
Guenel P, Rasmark P, Andersen JB et al. Incidence of cancer in persons with occupational exposure to electromagnetic fields in Denmark. Br J Ind Med 1993; 42: 191–5.
Vågerö D, Ahlbom A, Olin R, Sahlsten S. Cancer morbidity among workers in the telecommunication industry. Br J Ind Med 1985; 42: 191–5.
Vågerö D, Olin R. Incidence of cancer in the electronics industry: Using the new Swedish Cancer Environment Registry as a screening instrument. Br J Ind Med 1983; 40: 188–92.
Wertheimer N, Leeper ED. Magnetic field exposure related to cancer subtypes. Ann N Y Acad Sci 1987; 502: 43.
Demers PA, Thomas DB, Rosenblatt KA et al. Occupational exposure to electromagnetic radiation and breast cancer in males. Am J Epidemiol 1991; 134: 340.
Matanoski G, Elliot E, Breysse P. Cancer incidence in New York telephone workers. Lancet 1991; 337: 737.
Tynes T, Andersen A. Electromagnetic fields and male breast cancer. Lancet 1990; 336: 1596.
Stevens RG. Electric power use and breast cancer: a hypothesis. Am J Epidemiol 1987; 125: 556–61.
Stevens RG, Davis S, Thomas DB, Anderson LE, Wilson BW. Electric power, pineal function, and the risk of cancer. FASEB J 1992; 6: 853–60.
World Health Organization. Electromagnetic Fields (300 Hz to 300 GHz). Geneva, Switzerland: 1993; Environmental Health Criteria 137.
Milham S. Increased mortality in amateur radio operators due to lymphatic and hematopoietic malignancies. Am J Epidemiol 1988; 127: 50–4.
Szmigielski S, Szudzinski A, Pietraszek A, Bielec M, Wrembel JK. Accelerated development of spontaneous and benzopyrene-induced skin cancer in mice exposed to 2450 MHz microwave radiation. Biolectromagnetics 1982; 3: 179–91.
Mayers CP, Habeshaw JA. Depression of phagocytosis: A non-thermal effect of microwave radiation as a potential hazard to health. Int J Radiat Biol 1973; 24: 449–61.
Pedersen E, Magnus K. Cancer Registration in Norway, 1953–54. Oslo, Norway: Norwegian Cancer Society, 1959.
World Health Organization. International Classification of Diseases, Seventh Revision, Geneva, Switzerland: WHO, 1957.
Kvåle G, Heuch I, Eide GE. A prospective study of reproductive factors and breast cancer. I. Parity. II. Age at first and last birth. Am J Epidemiol 1987; 126: 831–50.
International Standard of Classification. International Standard of Classification of Occupations (ISCO). Geneva, Switzerland: ISC, 1958.
Tynes T, Andersen A, Langmark F. Incidence of cancer in Norwegian workers potentially exposed to electromagnetic fields. Am J Epidemiol 1992; 136: 81–2.
Preston DL, Lubin JH, Pierce D, McConney M. Epicure. Seattle, WA (USA): Hirosoft International Corporation, 1993.
Statistical Software, Statistics and Epidemiology Research Corporation. EGRET. Seattle, WA (USA): SERC Inc., 1988.
Tamarkin L, Cohen M, Roselle D. Melafouronin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. Cancer Res 1981; 41: 4432–61.
Narito T, Kudo H. Effect of melatonin on B16 melanoma growth in athymic mice. Cancer Res 1985; 45: 4175–7.
Moolgavkar SH, Day NE, Stevens RG. Two-stage model for carcinogenesis: Epidemiology of breast cancer in females. JNCI 1980; 65: 559–69.
Boice JDJr, Stone BJ. Interaction between radiation and other breast cancer risk factors. In. Late Biological Effects of Ionizing Radiation. Vienna, Austria: International Atomic Energy Agency, 1978: 231–49.
International Radiation Protection Association (IRPA). IRPA Guidelines on Protection against Non-ionizing Radiation. New York, NY (USA): Pergamon Press, 1988.
Skotte J. Exposure of radio officers to radio frequency radiation on Danish merchant ships. Am Ind Hyg Assoc J 1984; 45: 791–5.
Rogot E, Sorlie PD, Johnson NJ et al. Second Data Book: a Mortality Study of 1.3 Million Persons by Demographic, Social and Economic Factors: 1979–1985 Follow-up. Bethesda, MD (USA): National Institute of Health, 1992; Pub. No. (NIH) 92–3297.
Harland JD, Liburdy RP. ELF inhibition and tamoxifen's action on MCF-7 cell proliferation. Abstract presented at the annual review meeting of research on biological effects of electric and magnetic fields from the generation, delivery and use of electricity. Albequerque, NM (USA), Nov. 6–10, 1994.
Additional information
Mssrs Tynes, Andersen, and Haldorsen are with the Cancer Registry of Norway, Oslo, Norway. Authors are also affiliated with the Radiation Protection Authority, Østerås (Ms Hannevik, Mr Tynes), and the University of Oslo, Physics Department, Oslo, Norway (Dr Vistnes). Address correspondence to Mr Tynes, Norwegian Radiation Protection Authority, Pilestredet 46, N-0167 Oslo, Norway.
Rights and permissions
About this article
Cite this article
Tynes, T., Hannevik, M., Andersen, A. et al. Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 7, 197–204 (1996). https://doi.org/10.1007/BF00051295
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00051295